BioCentury
ARTICLE | Clinical News

House dust mites sublingual immunotherapy tablet: Phase II/III data

February 24, 2014 8:00 AM UTC

Stallergenes said partner Shionogi reported data from the double-blind, Japanese Phase II/III S-524101 trial showing that house dust mites sublingual immunotherapy tablet met the primary endpoint of i...